Skip to Main Content (Press Enter)

Logo UNIBS
  • ×
  • Home
  • People
  • Organizations
  • Expertise & Skills
  • Outputs
  • Jobs
  • Degrees
  • Courses
  • Third Mission
  • Equipment

Expertise & Skills
Logo UNIBS

|

Expertise & Skills

unibs.it
  • ×
  • Home
  • People
  • Organizations
  • Expertise & Skills
  • Outputs
  • Jobs
  • Degrees
  • Courses
  • Third Mission
  • Equipment
  1. Outputs

Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy.

Abstract
Publication Date:
2009
CRIS type:
4.2 Abstract in Atti di convegno
List of contributors:
Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Vitolo, U; Pregno, P; Gobbi, M; Pierri, I; Di Raimondo, F; Stagno, F; FoĆ , R; Alimena, G; Breccia, M; Saglio, G; Rege Cambrin, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Rambaldi, A; Intermesoli, T; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Angelucci, E; Usala, E; Bosi, A; Santini, V; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M.
Authors of the University:
MALAGOLA MICHELE
RUSSO DOMENICO
Handle:
https://iris.unibs.it/handle/11379/31249
Book title:
14th Congress of the European Society of Haematology
Published in:
HAEMATOLOGICA
Journal
  • Support
  • Privacy
  • Use of cookies
  • Legal notes

Powered by VIVO | Designed by Cineca | 26.11.1.0